Global Antibiotics Market By Drug Class (Penicillin, Cephalosporin, Tetracycline, Aminoglycosides, Sulfonamides, Fluoroquinolone, Others) By Application (Urinary Tract Infections, Respiratory Infections, Skin Infections, Septicemia, Ear Infection, Gastrointestinal Infections, Other Applications) By Route of Administration (Oral, Parenteral, Topical, Others) By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow- spectrum Antibiotic) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2032
- Published date: Nov 2023
- Report ID: 65175
- Number of Pages: 205
- Format:
-
keyboard_arrow_up
-
-
- Pfizer Inc Company Profile
- Abbott Laboratories
- Sanofi S.A.
- GlaxoSmithKline plc.
- Bayer AG Company Profile
- Bristol-Myers Squibb Company
- Merck & Co, Inc.
- Johnson & Johnson
- Astellas Pharma Inc.
- Novartis AG Company Profile
- Melinta Therapeutics
- Bayer Healthcare
- Eli Lilly and Company
- Arixa Pharmaceuticals Inc.
- Other Key Players
- settingsSettings
Our Clients
- 65175
- Nov 2023
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
